Craig Beasley
Chief Technology Officer, BlueRock Therapeutics
Craig Beasley is listed as Chief Technology Officer, BlueRock Therapeutics. Craig is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Craig. Is this you? Claim this profile.
About
Craig Beasley is currently Chief Technology Officer at BlueRock Therapeutics. Since joining BlueRock in August of 2021, he is responsible for Technical Operations which includes cell line derivation, process development, manufacturing, facilities and engineering, lab operations, and analytical sciences. Prior to joining BlueRock, Craig served as Vice President, Cell Therapy Supply Chain and Patient Operations at Juno/BMS starting in 2016. He was responsible for BMS’s cell therapy assets (clinical and commercial stage). This includes demand and supply planning, patient operations, external manufacturing Prior to joining Juno Therapeutics, Craig was Vice President of Next Generation Manufacturing at Biogen. During his 17 years with Biogen, Craig held leadership positions throughout the technical operations group (Engineering, Manufacturing, Quality, and Supply Chain).
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Fireside Chat Speaker · 19 January 2027
- Session 4: iPSCs – what does the future hold? Part 2 Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Craig at events on B2DB.
- Dhruv Sareen Founding Director, (IPSC) Core Facility, Cedars-Sinai & Founding Executive Director · Cedars-Sinai Biomanufacturing Center 1 shared session
- Ignacio Willats Co-Founder & CCO · Mytos 1 shared session
- Kim Raineri Chief Technology Officer · Aspen Neuroscience 1 shared session
- Tunde Babalola Senior Vice President, Technical Operations & Quality · Fate Therapeutics 1 shared session